Covid-19 created the perfect storm for the pharma industry’s already challenged supply chain network. The pandemic augmented supply chain risk and exposed weak areas such as the lack of end-to ...

Current Trends In Pharma. Much of the dialogue surrounding GLP-1 drugs encapsulates the broader debates within the pharmaceutical industry about drug affordability, accessibility and the ...

Pharma industry to grow to $130 billion by 2030: Pharmexcil There is strong push from government to create ecosystem for innovation in discovery of drugs and medical technology: S.V. Veeramani ...